A Genome-Wide RNAi Screen Reveals MAP Kinase Phosphatases as Key ERK Pathway Regulators during Embryonic Stem Cell Differentiation

English version České info

Embryonic stem cells and induced pluripotent stem cells represent potentially important therapeutic agents in regenerative medicine. Complex interlinked transcriptional and signaling networks control the fate of these cells towards maintenance of pluripotency or differentiation. In this study we have focused on how mouse embryonic stem cells begin to differentiate and lose pluripotency and, in particular, the role that the ERK MAP kinase and GSK3 signaling pathways play in this process. Through a genome-wide siRNA screen we have identified more than 400 genes involved in loss of pluripotency and promoting the onset of differentiation. These genes were functionally associated with the ERK and/or GSK3 pathways, providing an important resource for studying the roles of these pathways in controlling escape from the pluripotent ground state. More detailed analysis identified MAP kinase phosphatases as a focal point of regulation and demonstrated an important role for these enzymes in controlling ERK activation kinetics and subsequently determining early embryonic stem cell fate decisions.

Vyšlo v časopise: A Genome-Wide RNAi Screen Reveals MAP Kinase Phosphatases as Key ERK Pathway Regulators during Embryonic Stem Cell Differentiation. PLoS Genet 8(12): e32767. doi:10.1371/journal.pgen.1003112
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003112

Souhrn

Zdroje

1. YamanakaS, BlauHM (2010) Nuclear reprogramming to a pluripotent state by three approaches. Nature 465: 704–712.

2. YoungRA (2011) Control of the embryonic stem cell state. Cell 144: 940–954.

3. SangesD, CosmaMP (2010) Reprogramming cell fate to pluripotency: the decision-making signalling pathways. Int J Dev Biol 54: 1575–1587.

4. DingL, Paszkowski-RogaczM, NitzscheA, SlabickiMM, HeningerAK, et al. (2009) A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell Stem Cell 4: 403–415.

5. HuG, KimJ, XuQ, LengY, OrkinSH, et al. (2009) A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev 23: 837–848.

6. ChiaNY, ChanYS, FengB, LuX, OrlovYL, et al. (2010) A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468: 316–320.

7. BlairK, WrayJ, SmithA (2011) The liberation of embryonic stem cells. PLoS Genet 7: e1002019 doi:10.1371/journal.pgen.1002019.

8. SmithAG, HeathJK, DonaldsonDD, WongGG, MoreauJ, et al. (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336: 688–690.

9. WilliamsRL, HiltonDJ, PeaseS, WillsonTA, StewartCL, et al. (1988) Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684–687.

10. YingQL, WrayJ, NicholsJ, Batlle-MoreraL, DobleB, et al. (2008) The ground state of embryonic stem cell self-renewal. Nature 453: 519–523.

11. WrayJ, KalkanT, SmithAG (2010) The ground state of pluripotency. Biochem Soc Trans 38: 1027–1032.

12. SmithA (2009) Design principles of pluripotency. EMBO Mol Med 1: 251–254.

13. NicholsJ, SilvaJ, RoodeM, SmithA (2009) Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 136: 3215–3222.

14. SilvaJ, BarrandonO, NicholsJ, KawaguchiJ, TheunissenTW, et al. (2008) Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 6: e253 doi:10.1371/journal.pbio.0060253.

15. SridharanR, TchieuJ, MasonMJ, YachechkoR, KuoyE, et al. (2009) Role of the murine reprogramming factors in the induction of pluripotency. Cell 136: 364–377.

16. HannaJ, ChengAW, SahaK, KimJ, LengnerCJ, et al. (2010) Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci USA 107: 9222–9227.

17. WangW, YangJ, LiuH, LuD, ChenX, et al. (2011) Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc Natl Acad Sci USA 108: 18283–18288.

18. KunathT, Saba-El-LeilMK, AlmousailleakhM, WrayJ, MelocheS, et al. (2007) FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134: 2895–2902.

19. StavridisMP, LunnJS, CollinsBJ, StoreyKG (2007) A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development 134: 2889–2894.

20. DoreyK, AmayaE (2010) FGF signalling: diverse roles during early vertebrate embryogenesis. Development 137: 3731–3742.

21. DreesenO, BrivanlouAH (2007) Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 3: 7–17.

22. HurEM, ZhouFQ (2010) GSK3 signalling in neural development. Nat Rev Neurosci 11: 539–551.

23. WrayJ, KalkanT, Gomez-LopezS, EckardtD, CookA, et al. (2011) Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol 13: 838–845.

24. YiF, PereiraL, HoffmanJA, ShyBR, YuenCM, et al. (2011) Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal. Nat Cell Biol 13: 762–770.

25. SokolSY (2011) Maintaining embryonic stem cell pluripotency with Wnt signaling. Development 138: 4341–4350.

26. WhitmarshAJ (2007) Regulation of gene transcription by mitogen-activated protein kinase signaling pathways. Biochim Biophys Acta 1773: 1285–1298.

27. YangSH, SharrocksAD, WhitmarshAJ (2003) Transcriptional regulation by the MAP kinase signaling cascades. Gene 320: 3–21.

28. ToyookaY, ShimosatoD, MurakamiK, TakahashiK, NiwaH (2008) Identification and characterization of subpopulations in undifferentiated ES cell culture. Development 135: 909–918.

29. ChenX, XuH, YuanP, FangF, HussM, et al. (2008) Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133: 1106–1117.

30. NiwaH, BurdonT, ChambersI, SmithA (1998) Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12: 2048–2060.

31. AbujarourR, EfeJ, DingS (2010) Genome-wide gain-of-function screen identifies novel regulators of pluripotency. Stem Cells 28: 1487–1497.

32. FazzioTG, HuffJT, PanningB (2008) An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity. Cell 134: 162–174.

33. KageyMH, NewmanJJ, BilodeauS, ZhanY, OrlandoDA, et al. (2010) Mediator and cohesin connect gene expression and chromatin architecture. Nature 467: 430–435.

34. ColeMF, JohnstoneSE, NewmanJJ, KageyMH, YoungRA (2008) Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev 22: 746–755.

35. GuoG, HuangY, HumphreysP, WangX, SmithA (2011) A PiggyBac-based recessive screening method to identify pluripotency regulators. PLoS ONE 6: e18189 doi:10.1371/journal.pone.0018189.

36. PengJC, ValouevA, SwigutT, ZhangJ, ZhaoY, et al. (2009) Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 139: 1290–1302.

37. JiangH, ShuklaA, WangX, ChenWY, BernsteinBE, et al. (2011) Role for Dpy-30 in ES cell-fate specification by regulation of H3K4 methylation within bivalent domains. Cell 144: 513–525.

38. WestermanBA, BraatAK, TaubN, PotmanM, VissersJH, et al. (2011) A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiation. J Exp Med 208: 2675–2689.

39. OwensDM, KeyseSM (2007) Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26: 3203–3213.

40. MarksH, KalkanT, MenafraR, DenissovS, JonesK, et al. (2012) The transcriptional and epigenomic foundations of ground state pluripotency. Cell 149: 590–604.

41. BermudezO, PagèsG, GimondC (2010) The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. Am J Physiol Cell Physiol 299: C189–C202.

42. LiZ, FeiT, ZhangJ, ZhuG, WangL, et al. (2012) BMP4 Signaling Acts via Dual-Specificity Phosphatase 9 to Control ERK Activity in Mouse Embryonic Stem Cells. Cell Stem Cell 10: 171–182.

43. JaenischR, YoungR (2008) Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132: 567–582.

44. SeidelJJ, GravesBJ (2002) An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. Genes Dev 16: 127–137.

45. LeppäS, SaffrichR, AnsorgeW, BohmannD (1998) Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J 17: 4404–4413.

46. AsadaS, DaitokuH, MatsuzakiH, SaitoT, SudoT, et al. (2007) Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal 19: 519–527.

47. SapkotaG, AlarcónC, SpagnoliFM, BrivanlouAH, MassaguéJ (2007) Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 25: 441–454.

48. O'DonnellA, YangSH, SharrocksAD (2008) MAP kinase-mediated c-fos regulation relies on a histone acetylation relay switch. Mol Cell 29: 780–785.

49. SnelB, LehmannG, BorkP, HuynenMA (2000) STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res 28: 3442–3444.

50. HuangDW, ShermanBT, LempickiRA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1–13.

51. SupekF, BošnjakM, ŠkuncaN, ŠmucT (2011) REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE 6: e21800 doi:10.1371/journal.pone.0021800.